According to Kezar Life Sciences's latest financial reports the company's current revenue (TTM) is A$10.49 M. In 2023 the company made a revenue of A$10.27 M an increase over the revenue in the year 2022 that were of N/A.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.